The global anastomosis devices market size is anticipated to reach USD 5.89 billion by 2030 according to a new study by Polaris Market Research. The report “Anastomosis Devices Market Share, Size, Trends, Industry Analysis Report, By End-Use (Hospitals, Ambulatory Surgical Centers & Clinics); By Application; By Type; By Region; Segment Forecast, 2022 - 2030” gives a comprehensive insight into current market dynamics and provides analysis on future market growth.
The growth of the industry is majorly driven by the rising incidence of chronic diseases and the significant increase in the number of surgical cases. In addition, the growing demand for minimally invasive surgeries coupled with the high prevalence of target diseases is positively influencing the industry's growth. Furthermore, many recent developments have been made in the industry, such as circular stapler anastomosis and linear stapler anastomosis.
Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/anastomosis-devices-market/request-for-sample
North America holds the largest share in the global market. Innovations in these devices coupled with the presence of multi-specialty hospitals in the region favor its growth. APAC is projected to register the highest growth rate over the study period, owing to a rise in the number of colon and intestinal surgeries.
Adoption of such surgeries has grown manifold with booming middle-class disposable income and high investments in the private hospital chains. Surgical staplers garnered the largest revenue share in the global market and are also anticipated to register the highest growth rate. This is majorly due to high adoption and preferred choice among surgeons during surgical interventions. These staplers are also known to be the gold standard in surgical operations and are very easy to use.
Market participants such as Peters Surgical, Ethicon, Getinge, LivaNova PLC, MAQUET Holding, Medtronic, B. Braun, Novare Surgical Systems, Aesdex, and Vitalitec International are some of the key prominent players operating in the global market.
With a spike in chronic diseases over the past decade, various technological developments were undertaken by device companies to enhance anastomosis devices in terms of their durability and working. For instance, in August 2022, a team of researchers at “Johns Hopkins University” has developed a prototype of autonomous robot surgery. This is expected to provide efficacy and safety to intestinal, laparoscopic surgeries, and other soft tissue surgeries. This will increase the success rate and avoid revision surgeries, coupled with a steep decline in-hospital stay and medical costs in the anastomosis procedures.
Polaris Market Research has segmented the anastomosis devices market report on the basis of type, end-use, application, and region:
Anastomosis Devices, Type Outlook (Revenue - USD Billion, 2018 - 2030)
Anastomosis Devices, Application Outlook (Revenue - USD Billion, 2018 - 2030)
Anastomosis Devices, End-Use Outlook (Revenue - USD Billion, 2018 - 2030)
Anastomosis Devices, Regional Outlook (Revenue - USD Billion, 2018 - 2030)